Funder: National Institutes of Health
Due Dates: February 16, 2025 (New) | March 16, 2025 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $275,000 direct costs over 2 years; no more than $200,000 in any single year; max project period: 2 years.
Summary: Supports exploratory, early-stage research using microorganisms or their products for cancer imaging, therapy, or diagnostics, focusing on mechanistic and preclinical studies.
Key Information: Clinical trials are not allowed; only basic and preclinical research in cell culture or animal models is supported.